RPGR gene therapy presents challenges in cloning the coding sequence
<p><strong>Introduction:</strong> Currently, there are three Phase I/II clinical trials based on gene therapy ongoing to test different AAV.RPGR or deleted RPGR vectors on patients affected by X-linked retinitis pigmentosa. These three vectors differ in the adeno-associated viral (...
Váldodahkkit: | Martinez-Fernandez De La Camara, C, Cehajic-Kapetanovic, J, MacLaren, RE |
---|---|
Materiálatiipa: | Journal article |
Giella: | English |
Almmustuhtton: |
Taylor and Francis
2019
|
Geahča maid
-
Clinical applications of microperimetry in RPGR-related retinitis pigmentosa: a review
Dahkki: Buckley, TMW, et al.
Almmustuhtton: (2021) -
Characterizing visual fields in RPGR related retinitis pigmentosa using octopus static-automated perimetry
Dahkki: Buckley, TMW, et al.
Almmustuhtton: (2022) -
Association of a novel intronic variant in RPGR with hypomorphic phenotype of x-linked retinitis pigmentosa
Dahkki: Cehajic-Kapetanovic, J, et al.
Almmustuhtton: (2020) -
Microperimetry as an outcome measure in RPGR-associated retinitis pigmentosa clinical trials
Dahkki: Taylor, LJ, et al.
Almmustuhtton: (2023) -
Low luminance visual acuity and low luminance deficit in choroideremia and RPGR-associated retinitis pigmentosa
Dahkki: Wood, LJ, et al.
Almmustuhtton: (2021)